Takeda launches Adynovate to advance prophylaxis treatment for haemophilia patients in India Read more
US FDA approves Takeda’s Livtencity to treat people with post-transplant Cytomegalovirus infection Read more
Top 20 global pharma companies by MCap saw 10.2 per cent rise in MCap in Q2 2020: GlobalData Read more